Prostate cancer is a serious oncological disease in males. There has been a significant escalation in the incidence of this malignancy in the Czech Republic and in developed countries of Europe recently. Conversely, in countries with an altered health system, a minor increase in new cases of this disease is recorded. The causes of the high incidence of prostate cancer in developed countries appear to be the introduction of the prostate specific antigen (PSA) test and prostate biopsy, an aging population, and the consequent increased risk of cancer. The possible contribution of physical and chemical carcinogens associated with environmental pollution and negative lifestyle changes should not be forgotten either. The mortality rate for prostate cancer remains stable, with a slight decline in recent years. The article provides an overview of trends in the incidence and mortality of prostate cancer in the Czech Republic and Europe.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne. 2016 Jan [Epub]
M Nesvadba, P Cmorej, A Mamova, O Slowik